Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Siwen Hu‐Lieskovan(University of California, Los Angeles), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Antoni Ribas(University of California, Los Angeles)
Cell
February 1, 2017
10.1016/j.cell.2017.01.017
Cited by 5,409Open Access
Full Text

Abstract

Related Papers

Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
Yasumasa Ishida, Yasutoshi Agata, Kei‐ichi Shibahara et al.|The EMBO Journal|1992|3.2k
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce et al.|Nature|2001|2.8k
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger, Riyue Bao, Thomas F. Gajewski|Nature|2015|2.8k
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
Haidong Dong, Gefeng Zhu, Koji Tamada et al.|Nature Medicine|1999|2.5k
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas, Igor Puzanov, Reinhard Dummer et al.|The Lancet Oncology|2015|1.6k